Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence are Not Due to a Placebo Effect: A Randomized, Double-Blind, Placebo Controlled Trial
Abstract:Percutaneous tibial nerve stimulation can be considered an effective treatment for detrusor overactivity incontinence with 71% of patients considered responders, while none of those treated with placebo was considered a responder. The relevance of a placebo effect seems to be negligible in this patient population.
“…Urge incontinence episodes per day decreased from 3/day at baseline to 0.3/day at 12 weeks vs. 1.8/ day at baseline to 1.0/day for sham (p<0.001). [19] In a randomized, controlled study, Finazzi-Agro et al [17] reported that PTNS significantly increased voided volume than sham treatment (150-186 mL in the PTNS treatment group vs. 146-150 mL in the sham group, p<0.001). In a urodynamic study, Klingler et al [21] reported that PTNS increased the mean total bladder capacity from 197 mL at baseline (range 35-349 mL) to 252 mL (range 78-384 mL, p<0.01) after 12 weeks of therapy.…”
Section: Discussionmentioning
confidence: 99%
“…[13] More than 30 studies regarding PTNS have been published. The earliest ones are case series or single-arm efficacy studies, [14][15][16] three are randomized, controlled trials, [9,17,18] and two are long-term follow-up studies of patients who were responders in the overactive bladder innovative therapy (OrBIT) and sham effectiveness in the treatment of overactive bladder symptoms (SUmiT) trials. [19,20] Over half of the patients receiving PTNS therapy in the SUmiT trial, a randomized, double-blinded, sham controlled study, reported moderate or marked improvement in bladder symptoms (54.5% in PTNS patients vs. 20.9% in sham, p<0.001).…”
Objective: To evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS), either alone or combined with an anticholinergic agent, in treating patients with an overactive bladder (OAB) in whom previous conservative treatment failed.
“…Urge incontinence episodes per day decreased from 3/day at baseline to 0.3/day at 12 weeks vs. 1.8/ day at baseline to 1.0/day for sham (p<0.001). [19] In a randomized, controlled study, Finazzi-Agro et al [17] reported that PTNS significantly increased voided volume than sham treatment (150-186 mL in the PTNS treatment group vs. 146-150 mL in the sham group, p<0.001). In a urodynamic study, Klingler et al [21] reported that PTNS increased the mean total bladder capacity from 197 mL at baseline (range 35-349 mL) to 252 mL (range 78-384 mL, p<0.01) after 12 weeks of therapy.…”
Section: Discussionmentioning
confidence: 99%
“…[13] More than 30 studies regarding PTNS have been published. The earliest ones are case series or single-arm efficacy studies, [14][15][16] three are randomized, controlled trials, [9,17,18] and two are long-term follow-up studies of patients who were responders in the overactive bladder innovative therapy (OrBIT) and sham effectiveness in the treatment of overactive bladder symptoms (SUmiT) trials. [19,20] Over half of the patients receiving PTNS therapy in the SUmiT trial, a randomized, double-blinded, sham controlled study, reported moderate or marked improvement in bladder symptoms (54.5% in PTNS patients vs. 20.9% in sham, p<0.001).…”
Objective: To evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS), either alone or combined with an anticholinergic agent, in treating patients with an overactive bladder (OAB) in whom previous conservative treatment failed.
“…When compared to sham procedure, the number or percentage of responders in PTNS group were statistically higher (p<0.01), not only in objective responses [32][33][34] but also in global response assessment (GRA) improvement or cure. 35 The significant reduction of symptoms in PTNS group compared to sham group were found in frequency, urinary incontinence, and nocturia episodes.…”
Section: Efficacymentioning
confidence: 99%
“…35 The significant reduction of symptoms in PTNS group compared to sham group were found in frequency, urinary incontinence, and nocturia episodes. 32,33,35 In the matter of voided volume, two studies comparing PTNS and sham procedure by Agro et al 33 In studies comparing PTNS and anti-muscarinic, there were variable results in changes of voiding diaries symptoms. Most of them showed significant reduction of symptoms in both groups with no significant difference.…”
ABSTRAK
ABSTRACTOveractive bladder (OAB) is a common condition that is experienced by around 455 million people (11% of the world population) and associated with significant impact in patients' quality of life. The first line treatments of OAB are conservative treatment and anti-muscarinic medication. For the refractory OAB patients, the treatment options available are surgical therapy, electrical stimulation, and botulinum toxin injection. Among them, percutaneous tibial nerve stimulation (PTNS) is a minimally invasive option that aims to stimulate sacral nerve plexus, a group of nerve that is responsible for regulation of bladder function. After its approval by food and drug administration (FDA) in 2007, PTNS revealed considerable promise in OAB management. In this review, several non-comparative and comparative studies comparing PTNS with sham procedure, anti-muscarinic therapy, and multimodal therapy combining PTNS and anti-muscarinic had supportive data to this consideration.
“…Vandoninck et al [26] evaluated 90 patients with colleagues [35] performed a study on cat's bladder and found that intravenous inhibition of the metabotropic glutamate receptors and opioid receptors reduced PTNS efficacy in bladder overactivity. The posterior tibial nerve stimulation effect on supraspinal centers has been verified in humans in a study published by Finazzi Agro and colleagues [36] in which they found a significant increase in amplitude of long latency somatosensory evoked potentials recorded 24 hours after termination of a 12 sessions PTNS.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.